news

July 8, 2020

Illumina Launches TruSight Software Suite to Accelerate the Identification of Genetic Diseases

Illumina, Inc. (NASDAQ: ILMN) is bringing turn-key data analysis solutions to accelerate and facilitate the adoption of whole-genome sequencing with the launch of the... Read More
July 8, 2020

Sema4 Introduces “Sema4 Signal™”, a New Family of Products and Services Delivering Data-driven Precision Oncology Solutions

Sema4, a patient-centered health intelligence company, today announced the launch of Sema4 Signal™, a new family of products and services providing data-driven precision oncology... Read More
July 8, 2020

Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Chugai Pharmaceutical

Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Chugai Pharmaceutical Co., Ltd., a member of the Roche Group, and has applied... Read More
July 7, 2020

University of Glasgow Awarded £38M to Deliver Game-Changing Precision Medicine Project

The University of Glasgow has been awarded £38m to create the Precision Medicine Living Lab – an internationally leading project focused on translating cutting-edge... Read More
July 1, 2020

PFIZER AND BIONTECH ANNOUNCE EARLY POSITIVE DATA FROM AN ONGOING PHASE 1/2 STUDY OF MRNA-BASED VACCINE CANDIDATE AGAINST SARS-COV-2

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced preliminary data from the most advanced of four investigational vaccine candidates from their... Read More
July 1, 2020

Genome Medical​ Raises $14 Million to Expand Virtual Clinical Genetics Care and Accelerate Telemedicine Technology Development

Genome Medical today announced that it has raised $14 million to expand its clinical genetics care and operations. The funds will specifically support the... Read More
July 1, 2020

Vidence, LLC Launched to Set Standard for High-Quality Cancer Data, Research and Analytics

Vidence, LLC, an oncology informatics company, was officially launched today as an independent entity to provide the world’s leading cancer researchers, innovators and providers... Read More
July 1, 2020

New Artificial Intelligence Based Cancer Clinical Trial Finder Mobile App

The SYNERGY-AI Cancer Clinical Trial Finder app gives cancer patients access to new treatment options that are being approved by the FDA so that... Read More
July 1, 2020

Quantabio RT-qPCR ToughMix Given Expanded Role in CDC COVID-19 Testing Protocol

Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced... Read More
June 23, 2020

WuXi NextCODE Restructures and Becomes Genuity Science

WuXi NextCODE today announced plans to restructure its operations and governance in order to best position the company for future growth, ground-breaking offerings for... Read More
June 23, 2020

Thermo Fisher Scientific and Daiichi Sankyo to Co-Develop Global Companion Diagnostic for Patients with Non-Small Cell Lung Cancer

– Thermo Fisher Scientific and Daiichi Sankyo have expanded their partnership by signing a new agreement to co-develop a companion diagnostic (CDx) that will... Read More
June 22, 2020

Taconic Biosciences to Distribute Critical COVID-19 Mouse Model

Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces an exclusive agreement with the University of Texas Medical Branch at... Read More
June 22, 2020

Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology

Invitae (NYSE: NVTA), a leading genetics company, and ArcherDX, a leading genomics analysis company democratizing precision oncology, today announced the companies have entered into... Read More
June 18, 2020

Rady Children’s Shows Genomic Sequencing for Infants in Intensive Care Yields Life-Changing Benefits and Medical Cost Savings

In a pilot study funded by the State of California, Rady Children’s Hospital-San Diego demonstrated that a rapid precision medicine program for critically ill... Read More
June 18, 2020

GNS Healthcare and Multiple Myeloma Research Foundation (MMRF) Announce a Five-Year Collaboration to Advance Precision Medicine

GNS Healthcare and the Multiple Myeloma Research Foundation (MMRF) today announced a five-year partnership to leverage the longitudinal multi-modal patient registry data from the... Read More
MORE NEWS